» Articles » PMID: 35935861

Potential Targets and Treatments Affect Oxidative Stress in Gliomas: An Overview of Molecular Mechanisms

Overview
Journal Front Pharmacol
Date 2022 Aug 8
PMID 35935861
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress refers to the imbalance between oxidation and antioxidant activity in the body. Oxygen is reduced by electrons as part of normal metabolism leading to the formation of various reactive oxygen species (ROS). ROS are the main cause of oxidative stress and can be assessed through direct detection. Oxidative stress is a double-edged phenomenon in that it has protective mechanisms that help to destroy bacteria and pathogens, however, increased ROS accumulation can lead to host cell apoptosis and damage. Glioma is one of the most common malignant tumors of the central nervous system and is characterized by changes in the redox state. Therapeutic regimens still encounter multiple obstacles and challenges. Glioma occurrence is related to increased free radical levels and decreased antioxidant defense responses. Oxidative stress is particularly important in the pathogenesis of gliomas, indicating that antioxidant therapy may be a means of treating tumors. This review evaluates oxidative stress and its effects on gliomas, describes the potential targets and therapeutic drugs in detail, and clarifies the effects of radiotherapy and chemotherapy on oxidative stress. These data may provide a reference for the development of precise therapeutic regimes of gliomas based on oxidative stress.

Citing Articles

Lavender Essential Oil and Its Terpenic Components Negatively Affect Tumor Properties in a Cell Model of Glioblastoma.

Russo M, Martella N, Gargano D, Fantasma F, Marcovecchio C, Russo V Molecules. 2025; 29(24.

PMID: 39770132 PMC: 11676467. DOI: 10.3390/molecules29246044.


The Role and Applied Value of Mitochondria in Glioma-Related Research.

Chen L, Zhang H, Shang C, Hong Y CNS Neurosci Ther. 2024; 30(12):e70121.

PMID: 39639571 PMC: 11621238. DOI: 10.1111/cns.70121.


Proteomics of tumor and serum samples from isocitrate dehydrogenase-wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?.

Clavreul A, Guette C, Lasla H, Rousseau A, Blanchet O, Henry C Mol Oncol. 2024; 18(11):2783-2800.

PMID: 38803161 PMC: 11547244. DOI: 10.1002/1878-0261.13668.


Oxidative stress in the brain-lung crosstalk: cellular and molecular perspectives.

Kong J, Fan R, Zhang Y, Jia Z, Zhang J, Pan H Front Aging Neurosci. 2024; 16:1389454.

PMID: 38633980 PMC: 11021774. DOI: 10.3389/fnagi.2024.1389454.


Targeting NF-κB signaling cascades of glioblastoma by a natural benzophenone, garcinol, via and molecular docking approaches.

Danish Rizvi S, Almazni I, Moawadh M, Alharbi Z, Helmi N, Alqahtani L Front Chem. 2024; 12:1352009.

PMID: 38435669 PMC: 10904546. DOI: 10.3389/fchem.2024.1352009.


References
1.
Hsieh C, Lee C, Liang J, Yu C, Shyu W . Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity. Oncol Rep. 2010; 24(6):1629-36. DOI: 10.3892/or_00001027. View

2.
Deryugina E, Bourdon M, Luo G, Reisfeld R, Strongin A . Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci. 1997; 110 ( Pt 19):2473-82. DOI: 10.1242/jcs.110.19.2473. View

3.
Chang J, Hu Y, Siegel E, Stanley L, Zhou Y . PAX6 increases glioma cell susceptibility to detachment and oxidative stress. J Neurooncol. 2007; 84(1):9-19. DOI: 10.1007/s11060-007-9347-x. View

4.
Silva L, Coelho P, Soares R, Prudencio C, Vieira M . Quinoxaline-1,4-dioxide derivatives inhibitory action in melanoma and brain tumor cells. Future Med Chem. 2019; 11(7):645-657. DOI: 10.4155/fmc-2018-0251. View

5.
Waris G, Ahsan H . Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog. 2006; 5:14. PMC: 1479806. DOI: 10.1186/1477-3163-5-14. View